targeted therapies
Showing 1 - 25 of >10,000
Specific Genetic Tests and Efficacy of Targeted Therapies in
Recruiting
- Non-small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Dec 26, 2022
Developing Novel Microbiota-Targeted Therapies for Irritable
Completed
- Irritable Bowel Syndrome
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Cancer Trial in Lexington (Therapeutic Intervention)
Recruiting
- Cancer
- Therapeutic Intervention
-
Lexington, KentuckyMarkey Cancer Center, University of Kentucky
Nov 18, 2022
Kinase Inhibitor Targeted Therapies
Not yet recruiting
- Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
- Measurement of drug concentrations
-
Rennes, France
- +2 more
Nov 7, 2022
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)
Active, not recruiting
- Renal Cell Carcinoma
- Perfusion CT scan
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)
Recruiting
- Lung Cancer
- +3 more
- Sensus Smartwatch Application
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Aug 26, 2022
Inflammatory Disease, Autoimmune Diseases Trial in Paris (Kineret, Humira, Stelara)
Recruiting
- Inflammatory Disease
- Autoimmune Diseases
- Kineret
- +5 more
-
Paris, FranceHôpital Cochin
Oct 10, 2022
Moderate to Severe Ulcerative Colitis Patients Treated With
Recruiting
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- Procedure: endoscopic biopsy
- +2 more
-
Nancy, Lorraine, FranceCentral Hospital
Jul 11, 2022
Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,
Not yet recruiting
- Slow-Flow Vascular Malformation
- +17 more
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Aug 7, 2023
PET/CT Characterization of Treatment Resistance
Recruiting
- Prostate Cancer
- F-fluorodeoxyglucose positron emission tomography (FDG PET)
- prostate-specific membrane antigen positron emission tomography (PSMA PET)
-
Madison, WisconsinUniversity of Wisconsin
Jan 24, 2023
HER2-HER3 Dimer in Tumour and Blood Samples From HER2 Positive
Recruiting
- HER2-positive Breast Cancer
- Acquisition of blood samples and tumour tissue samples (biopsies)
-
Brighton, United Kingdom
- +1 more
Nov 9, 2022
Targeted Therapies in BRAF Positive Metastatic Melanoma in US
Active, not recruiting
- Melanoma
- Encorafenib
- +5 more
-
New York, New YorkPfizer Investigational Site
Feb 18, 2022
Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)
Recruiting
- Chronic Myeloid Leukemia
- Pharmaceutical intervention
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 24, 2022
Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon Trial in United States (afatinib,
Completed
- Non-small Cell Lung Carcinoma
- +3 more
- afatinib
- +2 more
-
Denver, Colorado
- +7 more
Aug 17, 2022
CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)
Recruiting
- CLL
- Chronic Lymphocytic Leukemia
- Peripheral blood samples withdrawal
-
Milano, Italy
- +1 more
Jan 3, 2022
Gastric Cancer Trial in Craiova (Endoscopic ultrasound)
Recruiting
- Gastric Cancer
- Endoscopic ultrasound
-
Craiova, RomaniaResearch Center in Gastroenterology and Hepatology, University o
Sep 24, 2021
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Biospecimen Collection
- +9 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 1, 2023
Oncology Research Information Exchange Network Lung Cancer Study
Active, not recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
- No Intervention
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Multi-layer Data to Improve Diagnosis, Predict Therapy
Recruiting
- High Grade Ovarian Serous Adenocarcinoma
- WGS and RNA sequencing
- +2 more
-
Turku, FinlandTurku University Hospital
Apr 26, 2022
Rare Malignant Tumor Trial in Chuo-ku
Recruiting
- Rare Malignant Neoplasm
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital, Japan
Jan 19, 2022